Literature DB >> 21496570

Molecular biology of Huntington's disease.

Karen N McFarland1, Jang-Ho J Cha.   

Abstract

It has been more than 17 years since the causative mutation for Huntington's disease was discovered as the expansion of the triplet repeat in the N-terminal portion of the Huntingtin (HTT) gene. In the intervening time, researchers have discovered a great deal about Huntingtin's involvement in a number of cellular processes. However, the role of Huntingtin in the key pathogenic mechanism leading to neurodegeneration in the disease process has yet to be discovered. Here, we review the body of knowledge that has been uncovered since gene discovery and include discussions of the HTT gene, CAG triplet repeat expansion, HTT expression, protein features, posttranslational modifications, and many of its known protein functions and interactions. We also highlight potential pathogenic mechanisms that have come to light in recent years.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21496570     DOI: 10.1016/B978-0-444-52014-2.00003-3

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  6 in total

1.  DEFOG: discrete enrichment of functionally organized genes.

Authors:  Tobias Wittkop; Ari E Berman; K Mathew Fleisch; Sean D Mooney
Journal:  Integr Biol (Camb)       Date:  2012-06-18       Impact factor: 2.192

Review 2.  Therapy development in Huntington disease: From current strategies to emerging opportunities.

Authors:  Audrey S Dickey; Albert R La Spada
Journal:  Am J Med Genet A       Date:  2017-12-08       Impact factor: 2.802

3.  Microhomology-mediated DNA strand annealing and elongation by human DNA polymerases λ and β on normal and repetitive DNA sequences.

Authors:  Emmanuele Crespan; Tibor Czabany; Giovanni Maga; Ulrich Hübscher
Journal:  Nucleic Acids Res       Date:  2012-02-28       Impact factor: 16.971

4.  Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice.

Authors:  Marina Kovalenko; Ella Dragileva; Jason St Claire; Tammy Gillis; Jolene R Guide; Jaclyn New; Hualing Dong; Raju Kucherlapati; Melanie H Kucherlapati; Michelle E Ehrlich; Jong-Min Lee; Vanessa C Wheeler
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

5.  A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington's disease.

Authors:  Daniel Todd; Ian Gowers; Simon J Dowler; Michael D Wall; George McAllister; David F Fischer; Sipke Dijkstra; Silvina A Fratantoni; Rhea van de Bospoort; Jessica Veenman-Koepke; Geraldine Flynn; Jamshid Arjomand; Celia Dominguez; Ignacio Munoz-Sanjuan; John Wityak; Jonathan A Bard
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

6.  Hippo Signaling Pathway Dysregulation in Human Huntington's Disease Brain and Neuronal Stem Cells.

Authors:  Kaly A Mueller; Kelly E Glajch; Megan N Huizenga; Remi A Wilson; Eric J Granucci; Amanda M Dios; Adelaide R Tousley; Maria Iuliano; Elizabeth Weisman; Michael J LaQuaglia; Marian DiFiglia; Kimberly Kegel-Gleason; Khashayar Vakili; Ghazaleh Sadri-Vakili
Journal:  Sci Rep       Date:  2018-07-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.